Patients may be quietly coping with treatment burden

Self-administration challenges, needle fatigue, and other issues may be weighing patients down1,2

In a study of 75 adults living with hereditary angioedema (HAE), approximately 90% of patients say they have learned to tolerate difficult aspects of their treatment, while 75% of patients say they try not to think about the demanding nature of their treatment.1

Talk to your patients about their satisfaction with their current prophylactic therapy for HAE; prophylactic therapy should be individualized based on considerations such as3,4

Disease-related factors (physical, emotional, quality of life)

Treatment-related factors (route of administration, side effects, availability/supply)

Patient preference

Through shared decision making, patients are empowered to play a more active role in treatment decisions and be more compliant with their treatment, leading to better overall outcomes.

Patients have been waiting for an oral prophylactic therapy for HAE5

Data from a study of 75 patients with HAE demonstrate the preference for an oral preventative therapy.5

of the 48 patients on a prophylactic therapy would prefer an oral treatment if one were available even though they are satisfied with their current prophylactic therapy5

of the 48 patients on a prophylactic therapy agree that an oral prophylactic therapy would better fit their lives vs an injectable HAE medication5